SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Intel CEO Lip-Bu Tan: "We will remain focused" on cutting costs and complexity

Deel and Rippling corporate espionage case takes a turn as accused ‘spy’ agrees to cooperate

Bank Leumi CEO Hanan Friedman: Michael Dell is joining Leumi's tech fund

Palo Alto's Nir Zuk: “The cybersecurity market is shifting because of AI”

Buzz

Most popular

Daily

Weekly

1

Intel CEO Lip-Bu Tan: "We will remain focused" on cutting costs and complexity

2

a16z’s David Haber: “AI is making markets that weren’t attractive to software companies suddenly very compelling”

3

OpenAI raising $40 billion at a $300 billion valuation in record funding round

4

"We saved $350 million last year using AI agents"

5

Deel and Rippling corporate espionage case takes a turn as accused ‘spy’ agrees to cooperate

New Phase

2 stories about New Phase

Groundbreaking Israeli cancer treatment gets FDA approval for clinical trials in U.S.

09.06.24|Ariela Karmel

New Phase CEO Ofer Shalev spoke to CTech about their technology which turns advanced cancer into a chronic ailment, extending the lifespans and treating symptoms without any of the side effects associated with other existing treatments

וידאו Ctech Mind the tech NY conference – Ofer Shalev

“We change cancer from a fatal disease to a chronic ailment”

Ofer Shalev, Founder & CEO at New Phase, spoke to CTech during Mind the Tech NY about New Phase and the technology behind the company